ReviewFrontiers in immunology2025

Targeting lipid metabolic reprogramming to alleviate diabetic kidney disease: molecular insights and therapeutic strategies.

Wei Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.